Prosecution Insights
Last updated: October 02, 2026

Examiner: MARCETICH, ADAM M

Tech Center 3700 • Art Units: 3700 3761 3781

This examiner grants 73% of resolved cases

Analysis

Adam M. Marcetich has resolved 1366 cases in Art Unit 3700 of Tech Center 3700. His allowance rate is 72.7 percent. This 72.7 percent rate is a key metric for practitioners to evaluate when filing in this art unit. The data also shows an interview lift of 18.8 percent. This lift indicates the change in the probability of allowance associated with an examiner interview.

The median days to allowance is 1085. This 1085-day figure represents the duration of the prosecution process for cases that reach a grant. Practitioners should consider the 1366 resolved cases as a historical record of the examiner's work. The 72.7 percent allowance rate and 18.8 percent interview lift are central to the examination profile. The median pendency is a factor for managing client expectations.

Direct communication is a documented tactic, as shown by the lift. Applicants should review the allowance rate as they prepare their prosecution strategy. The cases provide a data set for understanding the examiner's approach in Tech Center 3700. The timeline is a measure of the time required to navigate Art Unit 3700 to a successful conclusion.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

72.7%
Allow Rate
+2.7% vs TC avg
1,390
Total Applications
+18.8%
Interview Lift
1085
Avg Prosecution Days
Based on 1366 resolved cases, 2023–2026

Rejection Statute Breakdown

3.0%
§101 Eligibility
15.4%
§102 Novelty
48.1%
§103 Obviousness
20.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18890230 ENDOLUMINAL TREATMENT DEVICES AND RELATED METHODS Non-Final OA Boston Scientific Scimed, Inc.
19027372 Methods Of Operating A Waste Collection Unit Including A Light Assembly Non-Final OA Stryker Corporation
18811236 DEVICES AND METHODS FOR TRANSVASCULAR DRAINAGE OF FLUIDS IN AN INTRACRANIAL EXTRAVASCULAR SPACE Non-Final OA Mayo Foundation for Medical Education and Research
18992036 APPARATUS, SYSTEMS AND METHODS FOR PURGING AN EXUDATE CANISTER Non-Final OA Solventum Intellectual Properties Company
16826828 SYSTEMS AND METHODS FOR IDENTIFYING MATERIAL DURING AN OPHTHALMIC PROCEDURE USING AC IMPEDANCE MEASUREMENT Non-Final OA Alcon Inc.
19005983 ANTI-INFECTION FLUIDIC CHANNEL Non-Final OA CALIFORNIA INSTITUTE OF TECHNOLOGY
18971810 Medical Device, Medical Device Assembly Including the Same, and Method of Reconstitution of a Pharmaceutical Composition Non-Final OA Becton, Dickinson and Company
18780699 CONNECTIVITY SET FOR CONNECTING A POST-PROCESSING UNIT TO AN APHERESIS DEVICE Non-Final OA Terumo BCT, Inc.
18247499 ADJUSTABLE SHUNTS WITH RESONANT CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS Final Rejection Shifamed Holdings, LLC
18569711 FLUID COLLECTION ASSEMBLIES EXHIBITING A RELATIVELY THIN SHAPE Final Rejection PUREWICK CORPORATION
18618801 Systems and Methods For Controlling The Risk Of Citrate Reactions During Apheresis Final Rejection Fenwal, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month